title: Acquired haemophilia in recipients of depot thioxanthenes.
abstract: We present two cases in which the occurrence of acquired haemophilia is associated with the use of depot preparations of the thioxanthenes zuclopenthixol and flupenthixol. These drugs have not previously been implicated in the aetiology of acquired haemophilia.
authors: Haemophilia and Thrombosis Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
authors: A J
authors: AJ
authors: Stewart
authors: L M
authors: LM
authors: Manson
authors: H
authors: H
authors: Dasani
authors: A
authors: A
authors: Beddall
authors: P
authors: P
authors: Collins
authors: M
authors: M
authors: Shima
authors: C A
authors: CA
authors: Ludlam
mesh_terms: D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001323:Autoantibodies / Q000276:immunology; D003006:Clopenthixol / Q000009:adverse effects*; D005169:Factor VIII / Q000276:immunology; D005260:Female; D005475:Flupenthixol / Q000009:adverse effects*; D006467:Hemophilia A / Q000209:etiology* / Q000276:immunology; D006801:Humans
chemical_list: D014150:Antipsychotic Agents; D001323:Autoantibodies; D005169:Factor VIII; D003006:Clopenthixol; D005475:Flupenthixol